+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioidentical Hormones Market by Product Type (Creams, Gels, Sprays), End User (Clinics, Home Care, Hospitals), Therapy Type, Delivery Method, Age Group, Gender - Global Forecast 2025-2030- Product Image
Bioidentical Hormones Market by Product Type (Creams, Gels, Sprays), End User (Clinics, Home Care, Hospitals), Therapy Type, Delivery Method, Age Group, Gender - Global Forecast 2025-2030- Product Image
Sale

Bioidentical Hormones Market by Product Type (Creams, Gels, Sprays), End User (Clinics, Home Care, Hospitals), Therapy Type, Delivery Method, Age Group, Gender - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011384
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bioidentical Hormones Market is attracting significant attention from healthcare leaders seeking proven advancements in hormone replacement therapies. Rising patient demand and innovations in molecule design and delivery methods are shaping how stakeholders approach therapy personalization and operational excellence.

Market Snapshot: Bioidentical Hormones Market Overview

The Bioidentical Hormones Market grew from USD 616.46 million in 2024 to USD 773.91 million in 2025. It is expected to continue growing at a CAGR of 25.09%, reaching USD 2.36 billion by 2030. Market growth reflects increasing acceptance and integration of bioidentical hormones into endocrine disorder management and broader therapeutic protocols. This upward trend is supported by evolving clinical practices, regulatory frameworks, and an expanding portfolio of delivery solutions aimed at optimizing both clinical outcomes and patient experience.

Scope & Segmentation

This report provides robust coverage across several market dimensions, enabling informed decision-making on product development, investment, and strategic positioning:

  • Product Types: Creams, Gels, Sprays, Tablets
  • End Users: Clinics, Home Care, Hospitals, Retail Pharmacies
  • Therapy Types: Estrogen, Progesterone, Testosterone
  • Delivery Methods: Injectable, Oral (Capsules, Tablets), Topical (Creams, Gels, Sprays)
  • Age Groups: 18–49, 50–64, 65+
  • Gender: Female, Male
  • Regions: Americas (including United States by major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Key Companies: BioTE Medical, LLC, SottoPelle, Actiza Pharmaceutical Private Limited, Defy Medical, Bayer AG, Papillon Medical, ZRT Laboratory, Neuva Aesthetics, The biostation

Key Takeaways for Senior Decision-Makers

  • The market is undergoing a shift towards patient-centered care supported by evidence-based validation, which is improving both safety and satisfaction levels in hormone therapies.
  • Providers are prioritizing individualized dosing regimens and leveraging advanced formulations for flexible delivery, ensuring compatibility with varied patient preferences and needs.
  • Ongoing collaboration between manufacturers, clinicians, and logistics partners is pivotal in maintaining uninterrupted supply and quality controls, especially amid regulatory and market changes.
  • Segmentation by therapy type reveals diversified application, with estrogen and testosterone dominating use cases in menopausal and age-related therapies, respectively.
  • Regional adoption rates are influenced by healthcare infrastructure, reimbursement support, and evolving regulatory policies, offering actionable intelligence for expansion strategies in both developed and emerging markets.
  • Innovation pipelines focus on extended-release systems and real-time monitoring tools, enabling enhanced patient adherence and more precise therapeutic adjustments.

Tariff Impact: Addressing 2025 United States Policy Dynamics

In 2025, the United States introduced a revised tariff regime affecting bioidentical hormone raw materials. Manufacturers responded by diversifying procurement channels, localizing production where viable, and establishing alternative sourcing partnerships. Such measures are designed to enhance resilience, manage input costs, and stabilize supply chains amid changing trade policies. Logistics providers have also recalibrated shipping strategies to minimize the effect of added import duties across global operations.

Methodology & Data Sources

This report is based on a rigorous multi-source research process, synthesizing secondary data from clinical studies, regulatory filings, and industry publications. Primary insights were gathered through interviews with endocrinologists, pharmacists, and supply chain and regulatory specialists, ensuring accurate validation of market trends and segmentation.

Bioidentical Hormones Market: Why This Report Matters

  • Enables forward-thinking resource allocation and product innovation by providing actionable intelligence on emerging technologies, delivery models, and therapy applications.
  • Equips market entrants and established leaders with granular segmentation and regional analysis to inform strategic market entry and expansion decisions.

Conclusion

The Bioidentical Hormones Market is positioned for sustained advancement as balanced stakeholder collaboration and responsive innovation drive new standards in personalized hormone care. This report provides the insight required for strategic planning and effective execution across the global value chain.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of customizable compounding techniques for personalized bioidentical hormone regimens
5.2. Integration of digital health platforms and wearable monitoring for optimizing bioidentical hormone dosing
5.3. Rising regulatory scrutiny driving development of standardized guidelines for bioidentical hormone products
5.4. Expansion of bioidentical hormone treatments into male menopause management and androgen replacement therapies
5.5. Increasing research into non-oral delivery systems like transdermal gels and subcutaneous implants for BHRT
5.6. Emergence of AI-driven predictive analytics for customizing long-term bioidentical hormone therapy plans
5.7. Collaborations between compounding pharmacies and telemedicine providers to expand remote BHRT access
5.8. Consumer-driven shift towards plant-sourced precursors influencing bioidentical hormone product portfolios
5.9. Surge in clinical studies assessing cardiovascular and bone health benefits of bioidentical hormone therapy
5.10. Growing focus on microbiome interactions affecting absorption and efficacy of bioidentical hormone treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioidentical Hormones Market, by Product Type
8.1. Introduction
8.2. Creams
8.3. Gels
8.4. Sprays
8.5. Tablets
9. Bioidentical Hormones Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
9.5. Retail Pharmacies
10. Bioidentical Hormones Market, by Therapy Type
10.1. Introduction
10.2. Estrogen
10.3. Progesterone
10.4. Testosterone
11. Bioidentical Hormones Market, by Delivery Method
11.1. Introduction
11.2. Injectable
11.3. Oral
11.3.1. Capsules
11.3.2. Tablets
11.4. Topical
11.4.1. Creams
11.4.2. Gels
11.4.3. Sprays
12. Bioidentical Hormones Market, by Age Group
12.1. Introduction
12.2. 18-49
12.3. 50-64
12.4. 65+
13. Bioidentical Hormones Market, by Gender
13.1. Introduction
13.2. Female
13.3. Male
14. Americas Bioidentical Hormones Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Bioidentical Hormones Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Bioidentical Hormones Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. BioTE Medical, LLC,
17.3.2. SottoPelle
17.3.3. Actiza Pharmaceutical Private Limited
17.3.4. Defy Medical
17.3.5. Bayer AG
17.3.6. Papillon Medical
17.3.7. Defy Medical
17.3.8. ZRT Laboratory
17.3.9. Neuva Aesthetics
17.3.10. The biostation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOIDENTICAL HORMONES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOIDENTICAL HORMONES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOIDENTICAL HORMONES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOIDENTICAL HORMONES MARKET: RESEARCHAI
FIGURE 28. BIOIDENTICAL HORMONES MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOIDENTICAL HORMONES MARKET: RESEARCHCONTACTS
FIGURE 30. BIOIDENTICAL HORMONES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOIDENTICAL HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 18-49, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 18-49, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 50-64, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 50-64, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 65+, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 65+, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 116. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 117. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 118. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 119. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 120. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 215. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 218. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 219. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 230. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 231. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 234. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 235. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 255. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 260. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 261. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 262. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 263. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 264. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 265. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 266. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 267. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 270. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 276. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 277. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 278. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 279. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 282. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 283. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 286. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 334. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 335. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 340. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 341. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 342. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 343. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 344. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 345. DENMARK BIOIDENTICAL HORMONES MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

  • BioTE Medical, LLC,
  • SottoPelle
  • Actiza Pharmaceutical Private Limited
  • Defy Medical
  • Bayer AG
  • Papillon Medical
  • Defy Medical
  • ZRT Laboratory
  • Neuva Aesthetics
  • The biostation

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 773.91 Million
Forecasted Market Value ( USD ) by 2030 $ 2360 Million
Compound Annual Growth Rate25.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bioidentical Hormones Market Report 2025 - Product Image

Bioidentical Hormones Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Testosterone Replacement Therapy (TRT) - Global Strategic Business Report - Product Image

Testosterone Replacement Therapy (TRT) - Global Strategic Business Report

  • Report
  • 406 Pages
  • Global
From
Nutropin Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Nutropin Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Levothyroxine - Global Strategic Business Report - Product Image

Levothyroxine - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From

About the Bioidentical Hormones Market

Bioidentical hormones are biotechnological products that are chemically identical to hormones naturally produced by the human body. They are used to treat a variety of medical conditions, including menopause, andropause, and hormone imbalances. Bioidentical hormones are typically derived from plant sources, such as yams and soybeans, and are then synthesized in a laboratory to create a product that is identical to the hormones produced by the body. Bioidentical hormones are becoming increasingly popular due to their ability to provide relief from symptoms associated with hormone imbalances without the side effects associated with traditional hormone replacement therapies. They are also seen as a more natural alternative to synthetic hormones. The bioidentical hormones market is growing rapidly, driven by increasing awareness of the benefits of bioidentical hormones and the availability of more affordable products. The market is expected to continue to grow in the coming years as more people become aware of the potential benefits of bioidentical hormones. Some companies in the bioidentical hormones market include BioTE Medical, BHRT Solutions, and Compounding Solutions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.